Healthcare -
Biotechnology - NASDAQ - US
$ 1.5
-1.32 %
$ 22.3 M
Market Cap
-0.27
P/E
LGVN - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities LGVN - Longeveron Inc.
8.19 M
LAST VALUE
66.29%
2 YEAR CAGR
109.82%
5 YEAR CAGR
0.00%
10 YEAR CAGR